|
|
|
Keynote Speaker
Strategies and Innovations Toward the Rapid Development of the Cobicistat Drug Substance
 Richard Yu, Ph.D., Director, Process Development, Gilead Sciences, Inc.
The presentation will highlight the accelerated development of the cobicistat drug substance. The discussion will feature the integration of process research and development plans, innovations, and regulatory strategies taken throughout the lifecycle of the program up to the marketing approval application.
Sessions Include:
- Case Studies of API Synthesis
- Regulatory Challenges
- Focus on Flow/Continuous Processing
- Process Planning
- Case Studies II
|
Scientific Advisors:
 Neal Anderson, Ph.D., President, Anderson’s Process Solutions
 Matthew Ravn, Ph.D., Senior Scientist III, GPRD Process R&D, Abbott
 Ambarish Singh, Ph.D., Associate Director, CMC, Bristol-Myers Squibb
|
Pre-conference Short Courses*
June 12
Refining API Process Development for This Decade
Instructor: Neal Anderson, Ph.D., President,
Anderson’s Process Solutions
Incorporating Continuous Flow Chemistry
Instructors:
Nicholas Leadbeater, Ph.D., Associate Professor, Chemistry,
University of Connecticut
Bryan Li, Ph.D., Associate Research Fellow, Chemical R&D,
Pfizer Pharmaceutical Science
Timothy Braden, Process Chemist, Continuous Chemistry Group, Chemical Product R&D, Eli Lilly and Company
*Separate registration required
|
Featured Speakers
 Antonio Montalban, Ph.D., Director, Chemical R&D, Arena Pharmaceuticals
 Jay Srirangam, Ph.D., Associate Research Fellow, World Wide Phamraceutical Sciences, Pfizer
 Sandeep P. Modi, Ph.D., Group Director, CMC Documentation – Pharmaceutical Development, Bristol-Myers Squibb Co.
|
|
|
Conference
& Course Catalog
|